Nanostructured transdermal hormone replacement therapy for relieving menopausal symptoms: a confocal Raman spectroscopy study

OBJECTIVE: To determine the safety and efficacy of a transdermal nanostructured formulation of progesterone (10%) combined with estriol (0.1%) + estradiol (0.25%) for relieving postmenopausal symptoms. METHODS: A total of 66 postmenopausal Brazilian women with climacteric symptoms of natural menopau...

Descripción completa

Detalles Bibliográficos
Autores principales: Botelho, Marco Antonio, Queiroz, Dinalva Brito, Barros, Gisele, Guerreiro, Stela, Fechine, Pierre, Umbelino, Sonia, Lyra, Arão, Borges, Boniek, Freitas, Allan, de Queiroz, Danilo Caldas, Ruela, Ronaldo, Almeida, Jackson Guedes, Quintans, Lucindo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2014
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912337/
https://www.ncbi.nlm.nih.gov/pubmed/24519196
http://dx.doi.org/10.6061/clinics/2014(02)01

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912337/
https://www.ncbi.nlm.nih.gov/pubmed/24519196
http://dx.doi.org/10.6061/clinics/2014(02)01

Ejemplares similares